Sponsors (8)
The bill creates a comprehensive federal regulatory, safety, tax, and funding framework intended to standardize and make hemp‑derived cannabinoid products safer and more marketable nationwide, but it does so by imposing substantial compliance costs, narrowing some adult product access, limiting local/tribal control, and introducing enforcement, privacy, and supply‑chain risks.
Consumers (including veterans, seniors, families) gain stronger safety and labeling protections — mandatory warnings, per‑serving THC disclosure, allergen/ingredient lists, QR-linked certificates of analysis, ISO testing standards, product limits, and adverse‑event reporting — which should reduce unsafe, mislabeled, or risky hemp products on the market.
Businesses and regulators get clearer federal legal status and a unified framework — federal definitions of 'hemp' and 'hemp-derived cannabinoid product', designation under the FD&C Act, permit and tax regimes, and clarified product categories — reducing long‑running legal uncertainty for interstate commerce and oversight.
Hemp growers and producers benefit from looser cultivation loss rules and freer interstate transit — a higher 1% THC cultivation threshold and prohibition on blocking in‑transit compliant hemp — reducing destroyed crops and shipping interruptions for farmers and retailers.
Small hemp businesses, manufacturers, and wholesalers face substantially higher compliance costs and administrative burdens from new labeling/testing/ISO requirements, U.S.‑only sourcing preferences, permit and tax obligations, batch COAs/QR systems, and potential criminal/administrative penalties — risking higher consumer prices, business exits, and consolidation.
Adult consumers lose access to some existing products and formulations because of strict cannabinoid lists, per‑product maximums, and exclusions (including limits on non‑hemp producible cannabinoids), reducing product variety for lawful users.
State, territorial, and Tribal authorities may see reduced policymaking control — the bill preempts some local restrictions and limits the ability to block in‑transit compliant hemp, while conditional federal incentives (e.g., highway fund penalties) could pressure states to conform.
Based on analysis of 11 sections of legislative text.
Redefines hemp (raising THC cap to 1%), reclassifies many hemp-cannabinoid products under FDA law as foods/supplements, creates taxes and an oversight trust fund, permits MA coverage, and conditions highway funds on state impaired-driving rules.
Official title: To preserve lawful hemp commerce while protecting consumers from high-THC synthetic intoxicants, and for other purposes.
Introduced July 22, 2026 by Garland H. Barr · Last progress July 22, 2026
Creates a federal framework that redefines and legalizes a broader range of hemp and hemp-derived cannabinoid products, classifies many such products as foods/dietary supplements under the FD&C Act, authorizes Medicare Advantage plans and certain care-model incentives to cover or promote hemp-derived products, establishes new taxes and a dedicated trust fund for oversight, restricts anti-competitive practices by beverage manufacturers, limits distribution of unfinished hemp ingredients to permitted manufacturers, and conditions federal highway funds on State zero-tolerance impaired-driving laws for hemp impairment beginning in FY2027. The bill raises the statutory hemp THC ceiling to 1% (dry weight), preserves State/Tribal authority to regulate more-stringently, and phases implementation by requiring Treasury and agency regulations and permits.